Pustular psoriasis. Photo by Roland Tanglao via Wikimedia Commons Cutaneous paradoxical reactions to biologic therapies for psoriasis and atopic dermatitis are emerging as an important, if unpredictable, complication of these otherwise highly targeted treatments, according to Dr. Jeffrey Marcus Cohen . In a report in the Dec. 2025 issue of The Chronicle of Skin & Allergy , Dr. Cohen noted monoclonal antibodies have transformed care by addressing the underlying immunology of c

Erythroderma. Photo by: SalishSea2/Corinna Kennedy via Wikimedia Commons In a new study published in the Nature  journal Scientific...

A study by researchers at NYU Langone Health has identified a critical biological pathway driving inflammation in psoriasis, potentially...

The results of new Spanish research indicate that the pro-inflammatory cytokine IL-17 is central to skin aging and could potentially be...